Australian Genomics inviting expressions of interest for new rare disease flagships.

News > Published on 26 July 2017 > By merryn.pearce

Australian Genomics is now inviting expressions of interest for new Rare Disease Flagship projects, to commence in 2018 and run for two years.

Australian Genomics has implemented a program of research to demonstrate how the application of genomic data impacts the care of patients across a range of disorders. Our clinical flagships are central to this research model: they are nationally coordinated projects, founded in clinical practice, driving data through our programs to enable real-time evaluation of the impact of genomics on patient care.  

Applications for Rare Disease Flagships (2018 – 2020) are now open and will close 30 September 2017.

For more information or a copy of the application form, please contact Tiffany Boughtwood ( / 03 9936 6321).